Published: 20 February 2016
Author(s): I. Mikolasevic, S. Milic, D. Stimac, L. Zaputovic, V. Lukenda Zanko, T. Gulin, I. Jakopcic, D. Klaric, M. Gulin, L. Orlic
Section: Original Article
We investigated the association among long-term proton-pump inhibitors (PPIs) use with serum magnesium (Mg) levels in chronic hemodialysis (HD) patients, as well as possible association among PPI use and increased risk of cardiovascular (CVD) morbidity in HD patients.
